Table 3.
Multivariate analysis results for overall survival rate of cervical cancer patients using the Cox multiple regression method
| Characteristic | P value | HR | 95% CI |
|---|---|---|---|
| Stage (FIGO) | |||
| III vs. I–II | 0.398 | 0.63 | 0.21–1.85 |
| IV vs. I–II | 0.271 | 2.14 | 0.55–8.28 |
| Pre-treatment tumor size (≤4.0 cm vs. >4.0 cm) | 0.908 | 3.11 | 0.82–7.90 |
| Lymph node metastasis (yes vs. no) | 0.001 | 36.32 | 4.65–283.92 |
Patients with unknown lymph node status were excluded from the multivariate analysis with the characteristic of lymph node metastasis
HR hazard ratio, CI confidence interval, FIGO International Federation of Gynecology and Obstetrics